← Back to Search

Other

EDP-235 200mg for Coronavirus (SPRINT Trial)

Phase 2
Waitlist Available
Research Sponsored by Enanta Pharmaceuticals, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 through day 33

Summary

This trial is testing a new medication called EDP-235. It is aimed at adults who have mild or moderate COVID-19 but are not in the hospital. The medication works by stopping the virus from multiplying, which can help reduce symptoms and speed up recovery.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 through day 33
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 through day 33 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change From Baseline in COVID-19 Signs/Symptom

Side effects data

From 2023 Phase 2 trial • 231 Patients • NCT05616728
1%
Hepatotoxicity
100%
80%
60%
40%
20%
0%
Study treatment Arm
EDP-235 200mg
EDP-235 400mg
Placebo

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: EDP-235 400mgExperimental Treatment1 Intervention
Once a day orally for 5 days
Group II: EDP-235 200mgExperimental Treatment1 Intervention
Once a day orally for 5 days
Group III: PlaceboPlacebo Group1 Intervention
Once a day orally for 5 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EDP-235
2022
Completed Phase 2
~370

Find a Location

Who is running the clinical trial?

Enanta Pharmaceuticals, IncLead Sponsor
40 Previous Clinical Trials
2,890 Total Patients Enrolled
~79 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top